SCHEMBL21687697

SCHEMBL21687697

N#Cc1cccc([Si](c2ccccc2)(c2ccccc2)c2ccc(-c3ccc(-n4c5ccccc5c5cc(C#N)ccc54)cc3)cc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PTGER4 P35408 2/20 0.35
ADORA2A P29274 1/20 0.34
HDAC4 P56524 1/20 0.34
PDPK1 O15530 1/20 0.33
ALDH1A3 P47895 1/20 0.33
RARG P13631 1/20 0.32
MEN1 O00255 2/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C19 P33261 2/20 0.32
KMT2A Q03164 2/20 0.32
CLK4 Q9HAZ1 2/20 0.32
PGR P06401 1/20 0.32
MAPK1 P28482 1/20 0.32
LMNA P02545 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687832 0.96 ALDH1A3 (0.34) KDM4EADORA2APDPK1ALDH1A3RARG
SCHEMBL21687694 0.96 KDM4E (0.36) KDM4EATML3MBTL1PTGER4ADORA2A
SCHEMBL21688218 0.95 KDM4E (0.41) KDM4EATML3MBTL1PTGER4ADORA2A
SCHEMBL21687621 0.95 ATM (0.41) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL21687736 0.94 ATM (0.41) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL21687747 0.93 KDM4E (0.36) KDM4EATML3MBTL1PTGER4ADORA2A
SCHEMBL21687619 0.93 KDM4E (0.38) KDM4EATML3MBTL1PTGER4ADORA2A
SCHEMBL21687735 0.92 ALDH1A3 (0.35) KDM4EATML3MBTL1PTGER4ADORA2A
SCHEMBL21687834 0.92 ALDH1A3 (0.38) ADORA2AALDH1A3ALDH1A1CYP1A2CYP3A4
SCHEMBL21688031 0.92 G6PD (0.36) KDM4EATML3MBTL1PDPK1ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.